30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

SpyGlass Pharma Inc (SGP)

Track

The most recent insider trading activity occurred on February 9, 2026. This date saw significant buying activity from multiple insiders, including executives and investment firms. The total value of these buy transactions was substantial, indicating a strong collective interest in the company's stock.
Stock chart
Ticker: SGP Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
RA CAPITAL MANAGEMENT, L.P.
2 purchases — total 59,040,000 USD
Buy 9 Feb 2026
Value US$3,767,461.76 | Price 173.22 | Shares 50,989
Buy 9 Feb 2026
Value US$1,903,806.64 | Price 341.09 | Shares 14,012
Buy 9 Feb 2026
Value US$4,862,142.83 | Price 319.38 | Shares 18,906
Buy 9 Feb 2026
Value US$15,000,000.00 | Price 16.00 | Shares 937,500
Buy 9 Feb 2026
Value US$15,000,000.00 | Price 16.00 | Shares 937,500
Buy 9 Feb 2026
Value US$15,000,000.00 | Price 16.00 | Shares 937,500
Buy 9 Feb 2026
Value US$15,000,000.00 | Price 16.00 | Shares 937,500
Buy 9 Feb 2026
Value US$15,000,000.00 | Price 16.00 | Shares 937,500
Buy 9 Feb 2026
Value US$15,000,000.00 | Price 16.00 | Shares 937,500
Buy 9 Feb 2026
Value US$15,000,000.00 | Price 16.00 | Shares 937,500
Buy 9 Feb 2026
Value US$15,000,000.00 | Price 16.00 | Shares 937,500
Buy 9 Feb 2026
Value US$15,000,000.00 | Price 16.00 | Shares 937,500
Buy 9 Feb 2026
Value US$5,000,000.00 | Price 16.00 | Shares 312,500
Buy 9 Feb 2026
Value US$1,840,000.00 | Price 16.00 | Shares 115,000
Buy 9 Feb 2026
Value US$320,000.00 | Price 16.00 | Shares 20,000
Buy 9 Feb 2026
Value US$2,640,000.00 | Price 16.00 | Shares 165,000
Buy 9 Feb 2026
Value US$2,640,000.00 | Price 16.00 | Shares 165,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-11 2026-02-09 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
50,989 +10.6%
173.22
US$3,767,462 		50,989 +10.6% 173.22 US$3,767,462
2026-02-11 2026-02-09 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
14,012 +48.7%
341.09
US$1,903,807 		14,012 +48.7% 341.09 US$1,903,807
2026-02-11 2026-02-09 B Purchase
3.1
Yang Rick
Large shareholder
18,906 -4.5%
319.38
US$4,862,143 		18,906 -4.5% 319.38 US$4,862,143
2026-02-11 2026-02-09 B Purchase
3.1
Mathers Edward T
Large shareholder
937,500 +18.4%
16.00
US$15,000,000 		937,500 +18.4% 16.00 US$15,000,000
2026-02-11 2026-02-09 B Purchase
3.9
Walker Paul Edward
Large shareholder
937,500 +18.4%
16.00
US$15,000,000 		937,500 +18.4% 16.00 US$15,000,000
2026-02-11 2026-02-09 B Purchase
3.5
Chang Carmen
Large shareholder
937,500 +18.4%
16.00
US$15,000,000 		937,500 +18.4% 16.00 US$15,000,000
2026-02-11 2026-02-09 B Purchase
2.4
SANDELL SCOTT D
Large shareholder
937,500 +18.4%
16.00
US$15,000,000 		937,500 +18.4% 16.00 US$15,000,000
2026-02-11 2026-02-09 B Purchase
2.7
Makhzoumi Mohamad
Large shareholder
937,500 +18.4%
16.00
US$15,000,000 		937,500 +18.4% 16.00 US$15,000,000
2026-02-11 2026-02-09 B Purchase
2.6
Florence Anthony A. Jr.
Large shareholder
937,500 +18.4%
16.00
US$15,000,000 		937,500 +18.4% 16.00 US$15,000,000
2026-02-11 2026-02-09 B Purchase
1.5
Behbahani Ali
Non-Executive Director Large shareholder
937,500 +18.4%
16.00
US$15,000,000 		937,500 +18.4% 16.00 US$15,000,000
2026-02-11 2026-02-09 B Purchase
2.5
BASKETT FOREST
Large shareholder
937,500 +18.4%
16.00
US$15,000,000 		937,500 +18.4% 16.00 US$15,000,000
2026-02-11 2026-02-09 B Purchase
New Enterprise Associates 17, L.P.
Large shareholder
937,500 +18.4%
16.00
US$15,000,000 		937,500 +18.4% 16.00 US$15,000,000
2026-02-11 2026-02-09 B Purchase
1.6
Pardo Geoffrey B
Non-Executive Director
312,500 +16.7%
16.00
US$5,000,000 		312,500 +16.7% 16.00 US$5,000,000
2026-02-11 2026-02-09 B Purchase
Khan Bilal Arshad
Non-Executive Director
115,000 +84.3%
16.00
US$1,840,000 		115,000 +84.3% 16.00 US$1,840,000
2026-02-11 2026-02-09 B Purchase
Khan Bilal Arshad
Non-Executive Director
20,000 +367.0%
16.00
US$320,000 		20,000 +367.0% 16.00 US$320,000
2026-02-10 2026-02-09 B Purchase
3.4
Nielsen Kirk G.
Non-Executive Director
165,000 +5.2%
16.00
US$2,640,000 		165,000 +5.2% 16.00 US$2,640,000
2026-02-10 2026-02-09 B Purchase
Vensana Capital I GP, LLC
Large shareholder
165,000 +5.2%
16.00
US$2,640,000 		165,000 +5.2% 16.00 US$2,640,000
Explore more

More insider trading research around SpyGlass Pharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America